ALZHEIMER'S CLINICAL TRIAL CONSORTIUM FOR DOWN SYNDROME (ACTC-DS) TRIAL-READY COHORT - DOWN SYNDROME (TRC-DS)
Primary Objective
TRC-DS is a community of clinical trial volunteers who could help find a cure for Alzheimer's disease for people with Down syndrome.
Description
TRC-DS is part of a larger movement working with people with Down syndrome to advance Alzheimer's disease therapies and potential cures for this population. The Alzheimer's Clinical Trials Consortium-Down Syndrome (ACTC-DS) is a large collaboration of researchers conducting clinical trials for Alzheimer's disease in people with Down syndrome. The University of Colorado has partnered with the ACTC-DS to participate on the Anschutz Medical Campus. TRC-DS is the first of these studies and has the goal of creating a group of eligible volunteers with Down syndrome who are interested in participating in future clinical trials.
Details
Locations
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Joaquin Espinosa
Study ID
Protocol Number: 20-2692
More information available at ClinicalTrials.gov: NCT04165109
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers